United States Healthcare Equipment & Supplies

SpyGlass Pharma Inc (SGP)

Track

SpyGlass Pharma Inc. saw significant insider activity on February 9, 2026, with multiple individuals and entities executing substantial buy transactions. These purchases involved millions of shares across various stakeholders. No further insider trading activity has been reported in the last three months, and there have been no recent transactions to note.
Ticker: SGP Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
173.22
Quantity 50,989 +10.6%
Value US$3,767,462
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
341.09
Quantity 14,012 +48.7%
Value US$1,903,807
3.3
Yang Rick Large shareholder
Transaction date
Purchase
Price
319.38
Quantity 18,906 -4.5%
Value US$4,862,143
3.3
Mathers Edward T Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 937,500 +18.4%
Value US$15,000,000
3.9
Walker Paul Edward Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 937,500 +18.4%
Value US$15,000,000
3.6
Chang Carmen Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 937,500 +18.4%
Value US$15,000,000
2.4
SANDELL SCOTT D Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 937,500 +18.4%
Value US$15,000,000
2.9
Makhzoumi Mohamad Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 937,500 +18.4%
Value US$15,000,000
2.7
Florence Anthony A. Jr. Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 937,500 +18.4%
Value US$15,000,000
1.5
Behbahani Ali Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 937,500 +18.4%
Value US$15,000,000
2.5
BASKETT FOREST Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 937,500 +18.4%
Value US$15,000,000
1.6
Pardo Geoffrey B Non-Executive Director
Transaction date
Purchase
Price
16.00
Quantity 312,500 +16.7%
Value US$5,000,000
Khan Bilal Arshad Non-Executive Director
Transaction date
Purchase
Price
16.00
Quantity 115,000 +84.3%
Value US$1,840,000
Khan Bilal Arshad Non-Executive Director
Transaction date
Purchase
Price
16.00
Quantity 20,000 +367.0%
Value US$320,000
3.4
Nielsen Kirk G. Non-Executive Director
Transaction date
Purchase
Price
16.00
Quantity 165,000 +5.2%
Value US$2,640,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-11 2026-02-09 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
50,989 +10.6%
173.22
US$3,767,462 		50,989 +10.6% 173.22 US$3,767,462
2026-02-11 2026-02-09 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
14,012 +48.7%
341.09
US$1,903,807 		14,012 +48.7% 341.09 US$1,903,807
2026-02-11 2026-02-09 B Purchase
3.3
Yang Rick
Large shareholder
18,906 -4.5%
319.38
US$4,862,143 		18,906 -4.5% 319.38 US$4,862,143
2026-02-11 2026-02-09 B Purchase
3.3
Mathers Edward T
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
3.9
Walker Paul Edward
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
3.6
Chang Carmen
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
2.9
Makhzoumi Mohamad
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
2.7
Florence Anthony A. Jr.
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
1.5
Behbahani Ali
Non-Executive Director Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
2.5
BASKETT FOREST
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
2.5
New Enterprise Associates 17, L.P.
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
1.6
Pardo Geoffrey B
Non-Executive Director
312,500 +16.7%
16.00
US$5,000,000 		312,500 +16.7% 16.00 US$5,000,000
2026-02-11 2026-02-09 B Purchase
Khan Bilal Arshad
Non-Executive Director
115,000 +84.3%
16.00
US$1,840,000 		115,000 +84.3% 16.00 US$1,840,000
2026-02-11 2026-02-09 B Purchase
Khan Bilal Arshad
Non-Executive Director
20,000 +367.0%
16.00
US$320,000 		20,000 +367.0% 16.00 US$320,000
2026-02-10 2026-02-09 B Purchase
3.4
Nielsen Kirk G.
Non-Executive Director
165,000 +5.2%
16.00
US$2,640,000 		165,000 +5.2% 16.00 US$2,640,000
2026-02-10 2026-02-09 B Purchase
Vensana Capital I GP, LLC
Large shareholder
165,000 +5.2%
16.00
US$2,640,000 		165,000 +5.2% 16.00 US$2,640,000
Explore more

More insider trading research around SpyGlass Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America